Levin Capital Strategies’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-900
Closed -$231K 354
2021
Q4
$231K Hold
900
0.02% 261
2021
Q3
$218K Buy
+900
New +$220K 0.02% 271
2017
Q1
Sell
-10,500
Closed -$777K 318
2016
Q4
$777K Buy
10,500
+1,000
+11% +$74.9K 0.01% 180
2016
Q3
$718 Buy
+9,500
New +$727K 0.01% 201
2016
Q1
Sell
-3,500
Closed -$237K 342
2015
Q4
$237K Buy
+3,500
New +$244K ﹤0.01% 313

Other funds holding HCA

Levin Capital Strategies's HCA Position: Q1 2022 in Review

Levin Capital Strategies sold out of HCA Healthcare (HCA) in Q1 2022, closing a stake of 900 shares — an estimated $231K sold.

Levin Capital Strategies first reported a position in HCA in Q4 2015 and held it in 5 quarters. The position peaked at $777K in Q4 2016. 968 funds tracked by Wall St. Rank hold HCA as of Q1 2022.

  • Levin Capital Strategies reported no remaining HCA Healthcare position as of Q1 2022 after selling out during the quarter.
  • Levin Capital Strategies sold 900 HCA Healthcare shares in Q1 2022, an estimated $231K.
  • Levin Capital Strategies first reported a position in HCA Healthcare in Q4 2015 and held it in 5 quarters.
  • Levin Capital Strategies's HCA Healthcare position peaked at $777K in Q4 2016.
  • 968 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2022.

Based on Levin Capital Strategies's 13F filing for Q1 2022, filed 2 May 2022.